Abstract: The current disclosure relates binding proteins that bind human CD44v6. The binding proteins may be joined to an agent to form conjugated binding, where the agent may be an imaging or therapeutic agent, such as a radioisotope. The binding proteins or conjugated biding proteins, or pharmaceutical compositions thereof, may be used in medical treatments, such as cancer therapies, or in diagnosis and medical imaging. The binding proteins may also be used for engineering cells to express a chimeric antigen receptor having a binding protein of the present disclosure as antigen binding domain.
Name | Date | |
---|---|---|
1 | 202447092642-FORM-26 [05-12-2024(online)].pdf | 2024-12-05 |
2 | 202447092642-COMPLETE SPECIFICATION [27-11-2024(online)].pdf | 2024-11-27 |
3 | 202447092642-DECLARATION OF INVENTORSHIP (FORM 5) [27-11-2024(online)].pdf | 2024-11-27 |
4 | 202447092642-DRAWINGS [27-11-2024(online)].pdf | 2024-11-27 |
5 | 202447092642-FORM 1 [27-11-2024(online)].pdf | 2024-11-27 |
6 | 202447092642-FORM 18 [27-11-2024(online)].pdf | 2024-11-27 |
7 | 202447092642-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [27-11-2024(online)].pdf | 2024-11-27 |
8 | 202447092642-PRIORITY DOCUMENTS [27-11-2024(online)].pdf | 2024-11-27 |
9 | 202447092642-REQUEST FOR EXAMINATION (FORM-18) [27-11-2024(online)].pdf | 2024-11-27 |
10 | 202447092642-Sequence Listing in PDF [27-11-2024(online)].pdf | 2024-11-27 |
11 | 202447092642-Sequence Listing in txt [27-11-2024(online)].txt | 2024-11-27 |
13 | 202447092642-STATEMENT OF UNDERTAKING (FORM 3) [27-11-2024(online)].pdf | 2024-11-27 |